# Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome

> **NCT04741295** · NA · UNKNOWN · sponsor: **Nanjing University** · enrollment: 70 (estimated)

## Conditions studied

- Adenomyosis
- Assisted Reproductive Technology

## Interventions

- **DRUG:** Low molecular weight heparin

## Key facts

- **NCT ID:** NCT04741295
- **Lead sponsor:** Nanjing University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2021-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04741295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04741295, "Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04741295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*